MARKET

SGMOQ

SGMOQ

Sangamo Therapeutics Inc
OTCPK
0.148
+0.008
+5.64%
Closed 15:58 10/09 EDT
OPEN
0.143
PREV CLOSE
0.140
HIGH
0.151
LOW
0.140
VOLUME
1.60M
TURNOVER
235.31K
52 WEEK HIGH
0.765
52 WEEK LOW
0.030
MARKET CAP
61.31M
P/E (TTM)
-0.3866
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SGMOQ last week (0928-1002)?
Weekly Report · 4d ago
Weekly Report: what happened at SGMOQ last week (0921-0925)?
Weekly Report · 09/28 09:02
Sangamo Therapeutics Completes Fabry Gene Therapy Asset Sale
TipRanks · 09/21 21:02
Weekly Report: what happened at SGMOQ last week (0914-0918)?
Weekly Report · 09/21 09:02
Weekly Report: what happened at SGMOQ last week (0907-0911)?
Weekly Report · 09/14 09:02
Sangamo Therapeutics Completes Key Technology Asset Sale
TipRanks · 09/08 20:32
Weekly Report: what happened at SGMOQ last week (0831-0904)?
Weekly Report · 09/07 09:02
Weekly Report: what happened at SGMOQ last week (0824-0828)?
Weekly Report · 08/31 09:02
More
About SGMOQ
Sangamo Therapeutics, Inc. is a genomic medicine company that pioneered the development of zinc finger and capsid delivery technologies to address serious neurological and rare diseases. The Company's assets include clinical-stage programs ST-503 for chronic neuropathic pain and giroctocogene fitelparvovec for hemophilia A, as well as its cell therapy and regulatory T cell (T-Reg) assets. The Company is developing ST-503, an investigational epigenetic regulator for the treatment of intractable pain due to small fiber neuropathy (SFN), a type of chronic neuropathic pain. ST-503 uses an AAV vector carrying an engineered zinc finger repressor (ZFR) to specifically target the human gene, SCN9A, that encodes the Nav1.7 sodium channel and is critical for pain signaling. Giroctocogene fitelparvovec is a liver-tropic rAAV6 vector carrying a B-domain deleted F8 gene that is delivered through a single IV infusion. The Company is operating under court supervision in Chapter 11.

Webull offers Sangamo Therapeutics Inc stock information, including OTCPK: SGMOQ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGMOQ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGMOQ stock methods without spending real money on the virtual paper trading platform.